Although it was not directly tested in an AD model, HYP9 was shown to inhibit TRPC6 downregulation and reduce astrocytic apoptosis, cytotoxicity, and inflammatory responses in mice with ischemic/reperfusion damage [320,321]. The gene discussed is TRPC6; the disease is Alzheimer disease.